Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 823.00 | 763.50 | 1.0779 | 1.1027 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 651.00 | 763.50 | 0.8527 | 0.7981 |
| BT-20 | Erlotinib | 1 | uM | 7 | 625.00 | 270.29 | 801.00 | 763.50 | 1.0491 | 1.0650 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 689.00 | 763.50 | 0.9024 | 0.8675 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 763.50 | 0.0026 | -0.9622 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 3.00 | 763.50 | 0.0039 | -0.9504 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 750.00 | 763.50 | 0.9823 | 0.9763 | |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 724.00 | 763.50 | 0.9483 | 0.9303 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 625.00 | 270.29 | 798.00 | 763.50 | 1.0452 | 1.0599 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 507.00 | 763.50 | 0.6641 | 0.5218 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 270.29 | 771.00 | 763.50 | 1.0098 | 1.0131 |
| BT-20 | 17-AAG | 1 | uM | 7 | 625.00 | 270.29 | 320.00 | 763.50 | 0.4191 | 0.1193 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 625.00 | 270.29 | 951.00 | 763.50 | 1.2456 | 1.3157 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 625.00 | 270.29 | 304.00 | 763.50 | 0.3982 | 0.0816 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 862.00 | 763.50 | 1.1290 | 1.1687 | |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 804.00 | 763.50 | 1.0530 | 1.0702 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 625.00 | 270.29 | 333.00 | 763.50 | 0.4362 | 0.1494 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 897.00 | 763.50 | 1.1749 | 1.2271 | |
| BT-20 | Erlotinib | 10 | uM | 7 | 625.00 | 270.29 | 600.00 | 763.50 | 0.7859 | 0.7028 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 625.00 | 270.29 | 761.00 | 763.50 | 0.9967 | 0.9956 |
| BT-20 | Lapatinib | 10 | uM | 7 | 625.00 | 270.29 | 296.00 | 763.50 | 0.3877 | 0.0625 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 343.00 | 763.50 | 0.4493 | 0.1724 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 851.00 | 763.50 | 1.1146 | 1.1502 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 723.00 | 763.50 | 0.9470 | 0.9285 |
| BT-20 | Lapatinib | 1 | uM | 7 | 625.00 | 270.29 | 859.00 | 763.50 | 1.1251 | 1.1637 |